GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.300 $0.440 Friday, 19th Apr 2024 GLMD stock ended at $0.373. This is 1.56% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.30% from a day low at $0.370 to a day high of $0.379.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
2023-08-09 $0.93 $0.96 $0.88 $0.91 79 774
2023-08-08 $0.92 $0.94 $0.90 $0.92 40 387
2023-08-07 $1.08 $1.08 $0.91 $0.93 170 971
2023-08-04 $1.09 $1.09 $1.04 $1.05 42 254
2023-08-03 $1.05 $1.09 $1.03 $1.05 71 202
2023-08-02 $1.12 $1.12 $1.06 $1.06 65 891
2023-08-01 $1.15 $1.15 $1.06 $1.08 177 629
2023-07-31 $1.20 $1.21 $1.15 $1.15 75 329
2023-07-28 $1.20 $1.20 $1.15 $1.19 69 904
2023-07-27 $1.23 $1.26 $1.15 $1.16 134 346
2023-07-26 $1.18 $1.23 $1.16 $1.23 127 275
2023-07-25 $1.26 $1.26 $1.16 $1.19 279 815
2023-07-24 $1.24 $1.29 $1.16 $1.21 594 610
2023-07-21 $1.21 $1.26 $1.10 $1.15 701 026
2023-07-20 $1.30 $1.30 $1.21 $1.24 235 209
2023-07-19 $1.30 $1.32 $1.26 $1.29 186 284
2023-07-18 $1.35 $1.39 $1.29 $1.32 355 939
2023-07-17 $1.50 $1.50 $1.34 $1.36 337 205
2023-07-14 $2.12 $2.12 $1.40 $1.45 2 407 757
2023-07-13 $2.60 $2.87 $1.90 $2.08 4 254 451
2023-07-12 $2.30 $5.47 $2.30 $2.43 5 559 134
2023-07-11 $2.52 $2.52 $2.18 $2.28 119 448
2023-07-10 $2.90 $2.90 $2.52 $2.52 279 150
2023-07-07 $2.64 $2.77 $2.53 $2.65 48 161
2023-07-06 $2.90 $2.90 $2.52 $2.56 80 448
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT